top of page

Search


Surprising Absence of Co-Occurring Gene Alterations in A Recent Pan-Cancer Study
(First published on LinkedIn, 2/2017) The genetic theory of cancer postulates that distinct, sequential DNA alterations over time promote...
Luigi Catanzariti
Sep 13, 20184 min read
11 views
0 comments


Where next with liquid biopsy as a screening test for cancer – a global insurer’s (Swiss Re) inquiry
(First published on LinkedIn, 11/2016) Insurance companies are natural 'Futurists.' They are good at anticipating the future; their...
Luigi Catanzariti
Sep 13, 20183 min read
7 views
0 comments


The Trouble with Precision in 'Precision Medicine'
(First published on LinkedIn, January 2017) I am not sure who coined the term 'Precision Medicine,' but it is hard to escape its...
Luigi Catanzariti
Sep 13, 20184 min read
7 views
0 comments


Zykadia - A High Level Summary of the Companion Diagnostic Story
(First published on LinkedIn) Last year, I was riding a rented Triumph Thruxton in Utah, when I received the message that the data from...
Luigi Catanzariti
Sep 13, 20182 min read
22 views
0 comments


Diagnostic Partnering is Now an Integral Part of Pharma Strategy
(First published on LinkedIn) Phase I/II data can potentially be used to seek approval for oncology indications with high unmet clinical...
Luigi Catanzariti
Sep 13, 20181 min read
14 views
0 comments
bottom of page